Walleye Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,365
| Closed | -$354K | – | 2230 |
|
|
2025
Q1 | $354K | Sell |
11,365
-13,759
| -55% | -$428K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $641K | Buy |
+25,124
| New | +$641K | ﹤0.01% | 1078 |
|
|
2024
Q3 | – | Sell |
-37,635
| Closed | -$992K | – | 2808 |
|
|
2024
Q2 | $992K | Buy |
+37,635
| New | +$992K | ﹤0.01% | 1126 |
|
|
2023
Q4 | – | Sell |
-55,104
| Closed | -$1.5M | – | 2869 |
|
|
2023
Q3 | $1.5M | Buy |
55,104
+30,677
| +126% | +$833K | ﹤0.01% | 741 |
|
|
2023
Q2 | $751K | Buy |
24,427
+2,167
| +10% | +$66.6K | ﹤0.01% | 842 |
|
|
2023
Q1 | $802K | Buy |
+22,260
| New | +$802K | 0.01% | 814 |
|